Objective: This study examines temporal trends in treatment-related outcomes surrounding a diabetic ketoacidosis (DKA) performance improvement intervention consisting of mandated intensive care unit admission and implementation of a standardized management pathway, and identifies physical and biochemical characteristics associated with outcomes in this population. Results: The incidence of severe hyperchloremia and head CT utilization decreased during the study period. Among patients with severe DKA (presenting pH < 7.1), the intervention was associated with decreasing LOS and less variability in LOS. Lower pH at presentation was independently associated with increased risk for all outcomes except hypoglycemia, which was associated with higher pH. Patients treated for cerebral edema had a lower presenting mean systolic blood pressure z score (0.58 [95% confidence interval (CI) −0.02-1.17] vs 1.23 [1.13-1.33]) and a higher maximum mean systolic blood pressure (SBP) z score during hospitalization (3.75 [3.19-4.31] vs 2.48 [2.38-2.58]) compared to patients not receiving cerebral edema treatment. Blood pressure and cerebral edema remained significantly associated after covariate adjustment.
based on the best-available evidence with the aim of optimizing outcomes, though these guidelines also note existing equipoise, stating "no treatment strategy can be definitively recommended as being superior to another based on current evidence." 2 Institutional adoption of standardized approaches to DKA treatment based on these guidelines have been reported to reduce management variability and lead to improved outcomes, though limitations of these observational studies include small sample size, lack of comprehensive biochemical data and before-after analyses that do not account for management trends over time. [3] [4] [5] The electronic health record (EHR) and computerized order entry have been used to facilitate uniformity in the management of DKA through order sets and decision-support. 3 Spurred by Meaningful Use
Incentives, the emergence of electronic health data collection and storage has generated large repositories of structured data elements harbored by many institutions that can be readily searched and continue to accumulate. 6 The Institute of Medicine has recognized the potential of leveraging such data sources to support research endeavors and performance improvement initiatives as part of the strategic development of learning health care systems. [7] [8] [9] [10] Granular patient-level EHR data can be examined to elucidate elements of disease pathophysiology, such as the development of DKA-related cerebral edema, within large, readily available cohorts. This approach provides an opportunity to replicate and further validate the findings of smaller, sentinel studies and to explore the significance of incompletely understood disease features such as the presence of hypertension in children with DKA. 11 We sought to examine temporal trends in the management of DKA at our institution between 2009 and 2016 and identify presenting characteristics associated with treatment-related outcomes by querying an EHR-derived data warehouse. We hypothesized that system-level changes in care, including mandating pediatric intensive care unit (PICU) admission for DKA management and implementation of a standardized management pathway and order set based on international consensus guidelines, would be associated with improved outcomes during this period. 2 In addition, given that hypertension is common among children with DKA, even among those who do not experience neurologic decompensation, a secondary objective was to determine whether presenting blood pressure and maximum blood pressure during hospitalization are associated with treatment for cerebral edema in this population.
| METHODS

| Study design and setting
This is a single-center, retrospective cohort study of patients with DKA identified using structured EHR data. Approval was granted by were therefore eliminated. The distribution of height z scores was then re-centered to zero by adding the median of the calculated distribution to each z score. A subset of inpatient height measurements was compared to outpatient follow-up heights to ensure accuracy (see Supporting Information in Appendix S1). LOS was calculated as the difference of hospital admission time and discharge time, excluding time in the emergency department, and log-transformed due to high skew. The impact of time was considered both surrounding performance improvement interventions using a dichotomous intervention variable, as well as across the entire study period using a continuous week variable. Likelihood ratio tests for interaction were used to test whether trends in outcomes changed significantly before and after implementation of the intervention. Interaction terms with significant likelihood ratio tests (P < .2) were included in the final models. GCS scores were unavailable for 1 patient. One patient (0.08%) died.
| Data analysis
Patients in the postintervention period were older, presented with a higher pCO 2 , lower BUN and lower corrected Na + values (Table 1 ).
The proportion of encounters with treated cerebral edema was 2.4% for the entire cohort, with 2.5% of preintervention encounters and 2.4% of postintervention encounters receiving treatment, respectively ( Table 2 ). The incidence of cerebral edema did not differ between patients less than 5 years of age (2/81, 2.47%) vs those 5 years of age or older (28/1144, 2.45%). Sensitivity analysis demonstrated that different intervention cut points did not significantly influence the directional change in outcomes before and after the intervention (Tables S1 and S2 ). Regression analysis did not demonstrate any change in the incidence of patient encounters treated for cerebral edema or developing hypoglycemia with relation to the intervention (Table 3) . In multivariable analysis, the incidence of patient encounters developing severe hyperchloremia and undergoing head CT significantly decreased over the study period (Table 3) . pH was independently associated with all outcomes of interest, with lower pH associated with increased odds of developing all outcomes except hypoglycemia. Table 4 displays the association between pH and outcomes adjusted for the mean values of model covariates. The intervention was associated with a change in the slope of mean LOS for patients presenting with a pH less than 7.1, with a significant upward slope in the preintervention period changing to a significant downward slope in the postintervention period (Table S3 ). Figure 1 displays mean LOS (log-hours) for admissions of patients with known diabetes and severe DKA (n = 185). Post hoc multivariable analysis did not demonstrate any change in the incidence of hypokalemia over the study period or with relation to the intervention.
Data were available for 926 patients to calculate z scores of SBP.
Backward stepwise regression identified lower presenting pH, pCO 2 , and SBP z score, and a higher BUN to be significantly associated with treatment for cerebral edema during hospitalization (Table 5) . A higher maximum SBP z score during hospitalization was significantly associated with treatment for cerebral edema, and remained significantly associated after adjustment for presenting pH, pCO 2 , cor- The known relationship between hyperchloremia and LOS may be related to the significant declining trend in LOS observed in the Mean log LOS (log hours) .14 .74 .08 .08 .01 .01
All characteristics represent values at presentation to the study hospital. Adjusted for intervention, week (a continuous variable modeling time for the duration of the study period), pCO 2 , blood urea nitrogen, Glasgow coma scale score, corrected sodium, glucose, age and sex at presentation.
institution's preintervention LOS. Preintervention, mean LOS for patients in the present cohort was comparable to the reported national mean LOS for DKA at 38 children's hospitals (2.8 vs 2.5 days). remained hypertensive at their second outpatient follow-up. 11 The physiologic mechanism of hypertension in DKA is not completely understood, though it may be related to excess catecholamines, increased circulating cortisol, pain and anxiety, or release of antidiuretic hormone secondary to hyperosmolality. [26] [27] [28] Whether hypertension contributes to vasogenic cerebral edema in patients with DKA or serves as a protective response to preserve cerebral perfusion in the setting of elevated intracranial pressure is not known. 11 Profound dehydration in patients with severe DKA may mitigate a compensatory hypertensive response and contribute to cerebral ischemia. Previous studies reporting elevations in markers of neuronal injury, blood-brain barrier breakdown, basal ganglia lactate and neuroinflammation indicate a possible contribution of cerebral hypoperfusion to the development of cerebral edema in DKA. [29] [30] [31] [32] Lower presenting and higher maximum SBP in patients treated for cerebral edema compared to patients not treated suggests a time- edema. 12 To the best of our knowledge this is the first study to examine this diverse array of outcomes surrounding implementation of a management guideline for DKA. Incorporating time as a continuous variable in regression models revealed trends not apparent in the unadjusted, before-after analysis. Accordingly, we avoided misattributing declines in patients developing severe hyperchloremia and CVL insertions to implementation of the guideline. Our reported mortality of 0.08% compares favorably to that reported for other large cohorts of children with DKA (0.03%-0.18%). 12, 34 This study is limited by its retrospective design. Apparent severity of the cohort may have been reduced by exclusion of prehospital data in analysis, specifically at outside hospitals and during transport.
Likewise, patients who received treatment for cerebral edema prior to arrival but not following admission were not counted as cerebral edema cases. Defining cerebral edema as receiving treatment with either mannitol or 3% aqueous saline may have introduced bias by excluding patients with clinically relevant cerebral edema who did not receive treatment. The prevalence of cerebral edema in the current study of 2.4% is higher than studies that have relied on billing codes to identify cerebral edema, but is comparable to studies that have relied on clinical documentation. 3, 35 It is possible that the observed association between cerebral edema and pH, BUN and pCO 2 were driven by decisions to treat based on the known relationships between these parameters and cerebral edema. However, we expect that patient's clinical status guided ultimate treatment decisions in most cases.
| CONCLUSION
Using structured EHR data we have demonstrated that system-level changes in the management of DKA were associated with improved outcomes at our institution. Additionally, we replicated associations between presenting biochemical parameters and cerebral edema in the largest cohort to date and identified blood pressure as a potential harbinger of neurologic decompensation. Further study is warranted to better understand the relationship between blood pressure and cerebral edema in children with DKA.
